GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Otsuka Holdings Co Ltd (STU:OS1) » Definitions » Tax Expense

Otsuka Holdings Co (STU:OS1) Tax Expense : €181 Mil (TTM As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Otsuka Holdings Co Tax Expense?

Otsuka Holdings Co's tax expense for the months ended in Jun. 2024 was €61 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jun. 2024 was €181 Mil.


Otsuka Holdings Co Tax Expense Historical Data

The historical data trend for Otsuka Holdings Co's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Otsuka Holdings Co Tax Expense Chart

Otsuka Holdings Co Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 349.17 302.95 267.67 249.60 109.26

Otsuka Holdings Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.48 -195.77 130.07 61.13 185.70

Otsuka Holdings Co Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €181 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Otsuka Holdings Co  (STU:OS1) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Otsuka Holdings Co Tax Expense Related Terms

Thank you for viewing the detailed overview of Otsuka Holdings Co's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Otsuka Holdings Co Business Description

Traded in Other Exchanges
Address
2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, JPN, 101-0048
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.

Otsuka Holdings Co Headlines

No Headlines